有两家公司减少了在Regeneron的股份,尽管该公司报告收入丰厚。 Two firms reduced their holdings in Regeneron, despite the company reporting strong earnings.

Tidemark LLC和Robinson Smith财富顾问有限责任公司都减少了 Regenenron制药公司(NASDAQ:REGN)的股份。 Tidemark LLC and Robinson Smith Wealth Advisors LLC have both reduced their holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Tidemark现在拥有231个股份,下降了6.1%,Robinson Smith拥有536个股份,下降了7.6%。 Tidemark now owns 231 shares, down 6.1%, while Robinson Smith owns 536 shares, down 7.6%. Regeneron最近报告有强劲的季度,超过收入和收入预测。 Regeneron recently reported a strong quarter, exceeding earnings and revenue forecasts. 该公司的市场上限为729.1亿美元,其股票有中度购买评级,目标价格为973.13美元。 The company has a market cap of $72.91 billion, and its stock has a moderate buy rating with a target price of $973.13.